Novartis licenses vaccine candidates from U.S. group (Reuters)Reuters - Novartis AG will license a program of vaccines from U.S. group AlphaVax against cytomegalovirus (CMV) infections, which can cause disability in newborn babies, the Swiss drugmaker said on Monday.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_novartis.html